Benjamin Chong Email & Phone Number

Toronto, Ontario, Canada

• Secured more than 15 new partnerships resulting in co-development, licensing in/out, or regional marketing authorization• Managed 10 field research projects using internal data and information systems to ensure partnerships with CRO/CDMOs and co-development with local stem cell companies• Led a stem cell project with the R&D department and applied core project management principles resulting in initiation of the company’s next product development pipeline• Collaborated with R&D and manufacturing teams to support the development of 3 stem cell pipeline products• Represented the company and its pipeline products at Ausbiotech conference in Adelaide, Australia• Communicated technical and non-technical information with Korean and international partners utilizing full bilingual proficiency in Korean and English• Provided leadership, mentorship, and training to 10 junior team members on business processes• Interviewed and hired 5 new employees to create a high-performing Cellular Therapeutics team

Yeonsu-Gu, Incheon, Korea

• Developed business cases and secured approvals for contracts up to $50M capital investments; provided recommendations on production capacity, cost reduction, and project plans• Led IR Marketing projects, developed timelines, allocated resources, and ensured effective project completion in collaboration with Account Managers• Coordinated all project information including IR requests, status updates, and managed the development and submission of pharmaceutical review documents• Utilized financial management and modelling skills to manage project development budget which resulted in >10% increased funding by implementing financial growth strategies to investors• Prepared and delivered more than 100 IR presentations over 2-year period to potential investors• Performed competitive analysis of the pharmaceutical landscape and developed comprehensive monthly reports for senior management • Collaborated with investors to support funding initiatives for the development of Celltrion’s infliximab, rituximab, and trastuzumab biosimilar products (representing >$25B in global branded sales)• Managed Foreign Convertible Bonds (FCB) worth $300M; achieved 100% conversion into shares• Coordinated annual general shareholders meetings (>2,000 participants) to communicate organizational initiatives to investors• Wrote and presented press releases to educate investors on the company’s 7 biologic products• Nurtured and developed intimate relations with >100 institutional investors utilizing interpersonal and communication skills• Evaluated both the financial and non-financial aspects detailed by Analysts and managed alignment with company expectations• Managed cross-functional collaboration and planning between Presidents and VPs to develop multi-million-dollar capital investment strategies

Yeonsu-Gu, Incheon, Korea

• Collaborated with Celltrion Healthcare, an affiliated company, to set transfer price of Remsima® and with the engineering teams to design a new manufacturing plant• Strategized the development of 3 new drugs and created new business development and growth plans• Prepared and coordinated > 50 meetings for the decision of upper management in various projects• Reviewed and approved >30 contracts in Korean and English• Wrote Security Plan of BARDA (Biomedical Advanced Research and Development Authority) proposal for $250M funding, to initiate a global Phase 3 clinical trial of CT-P27 (a therapeutic monoclonal antibody against pandemic and seasonal influenza strains• Performed biweekly pharmaceutical industry reports for all employees

Ph.D., School Of Biological Science

Certificate, Employment In Life Sciences

Master'S Degree, School Of Biological Science

Teaching Assistant: Medical School, SNU

Bachelor Of Science, Cell/Cellular And Molecular Biology